PDF
NACI Rapid Response: Updated interim guidance on Imvamune® in the context of ongoing Monkeypox outbreaks
Organization: Public Health Agency of Canada (PHAC)Published: 2022
"In the context of the evolving multi-country monkeypox outbreak, this rapid response was undertaken to provide additional guidance on the use of the Imvamune® vaccine as pre-exposure vaccination, including the definition of priority populations for pre-exposure vaccination programs, and the relevance of dose-sparing strategies (i.e., extended dosing intervals and fractional dosing)." - NACI: Rapid Response: Updated interim guidance on Imvamune® in the context of ongoing Monkeypox outbreaks
Resource Group:
Implementation Tool
Product Type: Guide
Outbreaks and Pandemics
Outbreaks
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Management
Allocation and Distribution
Product Type: Guide
Category:
Monitoring and Surveillance,Outbreaks and Pandemics,Outbreaks,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Allocation and Distribution Monitoring and SurveillanceOutbreaks and Pandemics
Outbreaks
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Management
Allocation and Distribution
Audience:
Health Care Professional
Population: Adults
High Risk Adults
Pregnant and Breastfeeding People
Healthcare Personnel
Region: National
Population: Adults
High Risk Adults
Pregnant and Breastfeeding People
Healthcare Personnel
Region: National
Language:
English
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.